Levodopa-Responsive Aromatic L-Amino Acid Decarboxylase Deficiency

Annals of Neurology

Volumn 55, Issue 3, 2004, Pages 435-438

  Chang, Yuh Terng ^a,f   Sharma, Radhakant ^a   Marsh, J Lawrence ^b   McPherson, John D ^b,h   Bedell, Joey A ^b,g   Knust, Andreas ^c   Bräutigam, Christa ^d   Hoffmann, Georg F ^e   Hyland, Keith ^a,e  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DRK Children's Hospital   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^g Incyte Pharamceuticals ^*  (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 O METHYLDOPA; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CARBIDOPA; DOPAMINE; HYBRID PROTEIN; LEVODOPA; SEROTONIN;

AROMATIC LEVO AMINO ACID DECARBOXYLASE DEFICIENCY; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; DYSTONIA; ENZYME ACTIVE SITE; ENZYME DEFICIENCY; FEMALE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; HYPOKINESIA; IRRITABILITY; LETHARGY; MALE; MUSCLE HYPOTONIA; MYOCLONUS; OCULOGYRIC CRISIS; POINT MUTATION; PRIORITY JOURNAL; SIBLING; SITE DIRECTED MUTAGENESIS;

ADOLESCENT; ADULT; ALANINE; ANTIPARKINSON AGENTS; AROMATIC-L-AMINO-ACID DECARBOXYLASES; BINDING SITES; CARBIDOPA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEVELOPMENTAL DISABILITIES; DNA MUTATIONAL ANALYSIS; DRUG COMBINATIONS; ELECTROCHEMISTRY; FAMILY HEALTH; FEMALE; GLYCINE; HUMANS; LEVODOPA; MALE; MODELS, STRUCTURAL; POINT MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 1442352384     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20055     Document Type: Article

References (17)

1. Marsden CD. Parkinson's disease. J Neurol Neurosurg Psychiatry 1994;57:672-681.
2. Blau N, Thony B, Cotton RG, Hyland K. Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001:1725-1776.
3. Fletcher NA, Thompson PD, Scadding JW, Marsden CD. Successful treatment of childhood onset symptomatic dystonia with levodopa. J Neurol Neurosurg Psychiatry 1993;56:865-867.
4. Furukawa Y, Mizuno Y, Narabayashi H. Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia. Adv Neurol 1996;69:327-337.
5. Hyland K, Surtees RA, Rodeck C, Clayton PT. Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis. Neurology 1992;42:1980-1988.
6. Scherer LJ, McPherson JD, Wasmuth JJ, Marsh JL. Human dopa decarboxylase: localization to human chromosome 7p11 and characterization of hepatic cDNAs. Genomics 1992;13:469-471.
7. Ho SN, Hunt HD, Horton JRM, et al. Site directed mutagenesis by overlap extension using polymerase chain reaction. Gene 1989;77:51-59.
8. Poupon A, Jebai F, Labesse G, et al. Structure modelling and site-directed mutagenesis of the rat aromatic L-amino acid pyridoxal 5′-phosphate-dependent decarboxylase: a functional study. Proteins 1999;37:191-203.
9. Sayle RA, Milner-White EJ. RASMOL: biomolecular graphics for all. Trends Biochem Sci 1995;20:374.
10. Hyland K, Clayton PT. Aromatic L-amino acid decarboxylase deficiency: diagnostic methodology. Clin Chem 1992;38:2405-2410.
11. Maras B, Dominici P, Barra D, et al. Pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase. Primary structure and relationships to other amino acid decarboxylases. Eur J Biochem 1991;201:385-391.
12. Dominici P, Moore PS, Castellani S, et al. Mutation of cysteine 111 in Dopa decarboxylase leads to active site perturbation. Protein Sci 1997;6:2007-2015.
13. O'Malley KL, Harmon S, Moffat M, et al. The human aromatic L-amino acid decarboxylase gene can be alternatively spliced to generate unique protein isoforms. J Neurochem 1995;65:2409-2416.
14. Chang YT, Mues G, Hyland K. Alternative splicing in the coding region of human aromatic L-amino acid decarboxylase mRNA. Neurosci Lett 1996;202:157-160.
15. Brodie BB, Kuntzman R, Hirch CW, Costa E. Effects of decarboxylase inhibition on the biosynthesis of brain monoamines. Life Sci 1962;1:81-84.
16. Wright TRF, Black BC, Bishop CP, et al. The genetics of dopa decarboxylase in Drosophila melanogaster. V. Ddc and l(2)amd alleles: isolation, characterization and intragenic complementation. Mol Gen Genet 1982;188:18-26.
17. Chang YT, Mues G, McPherson JD, et al. Mutations in the human aromatic L-amino acid decarboxylase gene. J Inherit Metab Dis 1998;21:4.